3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Thoracic
10
Genitourinary
10
CNS
9
Gastrointestinal
8
Breast
7
Sarcoma
6
Gynecologic
3
Lymphoid
2
Plasma cell
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Endocrine
1
Classical hematology
1
Conditions
Neuroendocrine Tumors
130
Gastro-enteropancreatic neuroendocrine tumor
16
Pancreatic Neoplasms
14
Neoplasms
12
Stomach Neoplasms
8
Carcinoma, Neuroendocrine
8
Carcinoid Tumor
8
Prostatic Neoplasms
7
Lung Neoplasms
7
Carcinoma, Hepatocellular
7
Breast Neoplasms
7
Thyroid Neoplasms
6
Melanoma
6
Esophageal Neoplasms
6
Colonic Neoplasms
6
Rectal Neoplasms
5
Pheochromocytoma
5
Neoplasm Metastasis
5
Gastrointestinal Stromal Tumors
5
Carcinoma
5
Adenoma, Islet Cell
5
Adenocarcinoma
5
Testicular Neoplasms
4
Skin Neoplasms
4
Serotonin Syndrome
4
Sarcoma
4
Paraganglioma
4
Liver Neoplasms
4
Kidney Neoplasms
4
Head and Neck Neoplasms
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Disease Progression
×
NET
×
Clear all
NCT02270567
2025-11-13
RegisterNET
Wren Laboratories LLC
Enrolling by invitation
400 enrolled